Category Archives: Company News

Kineticos Announces New Life Sciences Disruptor Fund That Will Launch and Invest in Early Stage Biotechs

February 6, 2020 – Raleigh, NC – Kineticos announced today the Kineticos Disruptor Fund, a new life sciences investment fund. The fund will invest in disruptive modalities including cell therapy approaches such as CAR Ts, TCRs, TILs, gene therapy, gene editing, RNAi, immuno-oncology, and related precision medicine technologies.

The Kineticos Disruptor Fund will focus on large, unmet medical needs in oncology, neurosciences and rare diseases. In oncology, new approaches to solid tumors and “off the shelf” allogeneic cell therapies are immediate priorities. Kineticos will support entrepreneur-scientists and the biotech community through Series A funding.

In addition to supporting existing biotechs, the Kineticos Disruptor Fund will work with technology partners, including leading universities and other research centers. In this venture creation model, Kineticos will in-license technologies and build teams from its extensive community of advisors to advance new platforms.

Kineticos’ Founder and CEO, Shailesh Maingi states: “Our core mission is to advance life science research by supporting biotech companies in their pursuit of new treatments for patients. Yet, today with the most difficult to treat diseases, such as cancer, advancement is measured in months of increased life expectancy. With the advent and success of new disruptive technologies in life sciences, we believe how medicine is practiced today is fundamentally changing. For the first time, rational scientists, physicians, and entrepreneurs talk about a cure for cancer.”

He continued, “With the launch of the Kineticos Disruptor Fund, we are able to support the biotech community from concept to commercialization. I am very excited to work with my investment partners Mark Bamforth (Founder, Arranta Bio and previous Founder, Brammer Bio), Derek Hennecke (Founder, Xcelience) and Abe Maingi (VP, Kineticos) and I know of no better way to advance science than through capitalism.”

Paul Garofolo, Founder and CEO of Locus Biosciences, commented: “From the early days when we incubated with Kineticos, their team has been an important ally for Locus to lean on as we advanced our crPhage platform. At each stage of our company’s growth they have helped advise our team on how to best position our assets and overall company strategy for that stage of the company’s evolution. Their business and scientific insights have proven invaluable.”

Dr. Amit Vohra, Founder and CEO of Promaxo: “Since the early days of Promaxo, Kineticos has been an important ally. They have consistently focused on our needs and helped us advance our innovative modular MRI platform. Kineticos business and scientific acumen has resonated with our team.”

About Kineticos:

Kineticos is an award-winning organization supporting Biopharmaceutical and Precision Medicine firms. Launched in 2007, Kineticos initially concentrated on strategy, licensing, and market access support for Precision Medicine firms. In 2012, Kineticos launched its Biopharmaceutical practice. In 2016, Kineticos launched its internal think tank, The Kineticos Research Institute, which includes the Biotech CEO Confidence Index, The Disruptor26 podcast series, white papers, and other relevant content. In 2019, Kineticos was selected as Life Science Consultant of the Year.

In 2020, with the launch of the Kineticos Disruptor Fund, Kineticos recognized the need for a new model to support life science start-ups integrating intelligent funding, biotech expertise, and thoughtful execution. Kineticos has a deep and talented community of advisors to support biotech formation and funding. Ongoing relationships with larger pharmaceutical and biotech companies provide our portfolio companies with numerous opportunities for research collaborations and non-dilutive funding.

Additional information about Kineticos is available at www.kineticos.com. Inquiries can be sent to Philip Gialenios at philip.gialenios@kineticos.com.

Kineticos Welcomes New Senior Team Member – Dan McCormick

October 23, 2019 – Raleigh, NC – Kineticos Life Sciences announces the further expansion of their senior leadership team with the addition of Dan McCormick, Senior Vice President, Biopharma Practice.

Mr. McCormick brings to Kineticos a track record of over 20 years of success in biopharma, devices, and diagnostics, following 4 years of service as an officer in the Marine Corps. His broad perspective is a culmination of experience that spans numerous sales, marketing, value & access, strategy & operations, and medical affairs roles. He has worked across multiple specialties to engage providers, payers, and patient advocacy groups.

Prior to joining Kineticos, Mr. McCormick worked for Amgen, Baxter, and Dianon Pathology.  Along with a manufacturer’s perspective, Dan intimately understands the service side from both a client and contractor perspective, having held recent executive leadership accountabilities with a commercial contract organization. Much of his career has been spent building and operationalizing plans focused on profitable growth in US and Global markets. Applying his Commercial learnings to increase overall Medical Affairs effectiveness, Mr. McCormick has also developed innovative solutions for MSL organizations. Dan has earned a reputation for challenging the status quo to refocus resources for greatest impact using analytics, efficient channels, and technologies. Frequently solicited for his strategic expertise, his recent accolades include: PHARMAfield UK Magazine’s “Movers & Shakers” (Oct 2018) and PM360 Magazine’s “2018 Innovators” Award (Dec 2018).

Shailesh Maingi, CEO and Founder of Kineticos, stated, “We’re excited to have Dan join the firm. Dan brings with him a wealth of experience and a track record of success that will broaden and deepen Kineticos’ ability to deliver innovative solutions for our BioPharma clients. This addition to Kineticos Leadership Team is another step toward supporting our overall strategy and position the firm for our next phase of ongoing growth.”

When asked about his new role, Mr. McCormick stated, “Kineticos is at an inflection point. Along with expanding the senior leadership team, Shailesh’s recent integration of the Disruptor Fund to our offerings illustrates a strong commitment to fully support biopharma’s focus on patient outcomes. I’m excited to be a part of a firm with capabilities that now offer a full continuum of value, from start-up financing to Phase III support and beyond.“

Recently recognized with a 2019 Life Sciences Consultant of The Year award by the Triangle Business Journal, Kineticos Life Sciences continues to strengthen its position as an industry leader.

 

About Kineticos

Kineticos is a life science strategy consulting firm serving the Biopharmaceutical and Precision Medicine markets.  Our mission is simple: to improve patient outcomes. Every day, we see how therapeutic and precision medicine biotechs are changing the standard of care in medicine. With over 6,000 firms globally, biotechs are the catalysts of innovation in life sciences today. Yet, emerging companies often have limited resources to focus on strategy.

Addressing these challenges is at the core of our capabilities. Join us in our mission to improve patient outcomes by advancing the boundaries of scientific research.


Media Contact

Nathan Finger, Director of Marketing

nathan.finger@kineticos.com

Meet Kevin Hampton, SVP of Kineticos’ Early Stage Biopharma Practice

With Kineticos’ team expansion, Kevin Hampton has transitioned to leading the Biopharmaceutical Early Stage Practice. Kevin brings experience within Kineticos’ Finance, Marketing, Operations, and Commercial teams to grow the Biopharmaceutical Practice.

 

To learn more about Kevin Hampton and his plans for the Biopharmaceutical Practice click below.

 

Meet Kevin Hampton, SVP of Kineticos’ Early Stage Biopharma Practice

 

To connect with Kevin Hampton on LinkedIn click here

Kineticos Prepares for Next Phase of Growth Expanding Its Senior Team

September 16, 2019 – Raleigh, NC – Kineticos, a life sciences strategy consulting firm, today announces an expansion to the senior leadership team with the addition of Philip Gialenios, Chief Commercial Officer.

Mr. Gialenios brings to Kineticos a 30-year track record of success in the life science, biotech, and pharmaceutical industries building out commercial capabilities, leading marketing and sales efforts, and cultivating strong thought leader relationships. His prior experience and positions include Executive Commercial, Sales and Marketing Leadership, and Scientific roles at Novo Nordisk Pharmaceuticals, Sigma-Aldrich Corp, Charles Rivers Labs, and the United States EPA. Shailesh Maingi, CEO and Founder of Kineticos, stated, “We’re thrilled to have Philip as he brings a rich commercial background to the team.”

As Kineticos’ CCO, Mr. Gialenios will now lead commercial operations responsible for all business development, marketing, and sales efforts as the company positions itself for a next phase of commercial growth and ongoing success. When asked about his new role, Mr. Gialenios stated, “I’m excited to be part of such an established and great leadership team at Kineticos, recognized as the Triangle Business Journal’s 2019 Life Sciences Consultant of The Year.”

Kineticos is also pleased to announce two additional expansions to the management team.

Kevin Hampton has been promoted to Senior Vice President of Kineticos’ Biopharmaceutical practice, recognized as a key driver in the firm’s next phase of growth. Mr. Hampton has been an integral part of Kineticos’ growth over the past 6 years and brings a wealth of operational and commercial experience to this role. When asked, Shailesh Maingi, CEO and Founder of Kineticos, stated “We know that Kevin will provide the necessary focus and strong leadership our organization needs to take our Biopharmaceutical practice, our company’s largest growth driver, to the next level.”

Abe Maingi has been promoted to Vice President of Kineticos’ Precision Medicine practice. Abe has been with Kineticos for 6 plus years and previously ran Operations, managing all client projects and ensuring the delivery of consistent high-quality work. Additionally, Mr. Maingi is an instructor at University of North Carolina’s Kenan-Flagler School of Business, where he teaches a graduate level course. Shailesh Maingi stated, “We are excited for our customers as we transition Abe’s experience delivering over 150 successful projects into a new customer-facing leadership role.”

Shailesh went on to say, “With this restructuring, we have a much more focused management team, which will give our firm the best chance at achieving our mission, improving patient outcomes.”

 

About Kineticos

Kineticos is a life science strategy consulting firm serving the Biopharmaceutical and Precision Medicine markets.  Our mission is simple: to improve patient outcomes. Every day, we see how therapeutic and precision medicine biotechs are changing the standard of care in medicine. With over 6,000 firms globally, biotechs are the catalysts of innovation in life sciences today. Yet, emerging companies often have limited resources to focus on strategy.

Addressing these challenges is at the core of our capabilities. Join us in our mission to improve patient outcomes by advancing the boundaries of scientific research.


Media Contact

Nathan Finger, Director of Marketing

nathan.finger@kineticos.com

Kineticos Wins Triangle Business Journal’s 2019 Life Sciences Consultant of the Year

June 6, 2019 – Raleigh, NC – Kineticos, a management consulting firm serving the life sciences community, has been selected as Triangle Business Journal’s 2019 Life Sciences Consultant of the Year. Kineticos’ Founder and CEO, Shailesh Maingi received the award on behalf of the organization at Triangle Business Journal’s Annual Life Sciences Awards Ceremony at the Umstead Hotel and Spa.

Shailesh, who founded the company in 2007, had this to say: “This award is a testament of the great team we have at Kineticos and our team’s ability to address our biotechnology sponsor’s most complex problems. While we are incredibly grateful, we understand our work is not done. Our mission is to improve patient outcomes through our consulting team, our new biotechnology accelerator model, proprietary data analytics and internal think tank, Kineticos Research Institute.”

Kineticos Chief Commercial Officer, Kevin Hampton, who grew up in Raleigh, commented on this as well: “We have clients all over the world but to be recognized by a local publisher such as the TBJ means the world to us. This award is a result of the entire team’s hard work along with our passion to help our clients in their quest for developing life changing therapies for patients in need.”

Paul Garofolo, Founder and CEO of Locus Biosciences, congratulated the firm: “Kineticos was instrumental in helping Locus Biosciences launch our startup operations inside the RTP area. Their senior consulting teams worked alongside our founders to establish the initial sets of Target Product Profiles that underpinned our CRISPR-Cas3 platform technology play. We could not speak more highly of the Kineticos team and support provided to Locus in the early days of our endeavor.”

 

About Kineticos:

At Kineticos, our mission is simple: to improve patient outcomes. Every day, we see how therapeutic and precision medicine biotechs are changing the standard of care in medicine. With over 6,000 firms globally, biotechs are the catalysts of innovation in life sciences today. Yet, emerging and specialty biotechs often have limited resources to focus on strategy.

What’s the optimal R&D portfolio strategy in a highly regulated, complex and expensive clinical research environment? What’s an effective licensing strategy to identify potential partners and negotiate transactions? With reimbursement and pricing challenging, what’s the plan to ensure market access?

Addressing these challenges is at the core of our capabilities. Join us in our mission to improve patient outcomes by advancing the boundaries of scientific research.


Media Contact

Nathan Finger, Director of Marketing

nathan.finger@kineticos.com

Kineticos to Attend BIO 2017

Kineticos will be in San Diego, CA the week of June 19th attending BIO 2017.  We’d love to meet with biotech leaders seeking in- and out-licensing opportunities.  Kineticos has a methodical and proven approach to helping companies secure partnering meetings with interested pharmaceutical companies.

To learn more or to schedule a meeting at BIO, contact Kevin Hampton.


Kineticos is a specialized management consulting firm serving the life science
industry.

At Kineticos, we have a simple mission: to help our sponsors solve their most complex problems. We work exclusively within the life sciences ecosystem. And our focus is strategy, business development & licensing, market access, innovation and operational excellence. Our values start with an entrepreneurial culture focused on exceptional outcomes for our sponsors through deep engagements. We foster an environment where our business and life science experts can be creative, critical and collaborative thinkers. We value context and transparency over hierarchy and control. We do all of this to improve patient outcomes, our shared purpose with our sponsors.

For more information on Kineticos and its capabilities, please visit www.kineticos.com.

Kineticos to Sponsor February 27th Life Science Forum

Kineticos is serving as a lead sponsors for the upcoming Life Sciences Forum on February 27th at the NC Biotech Center in the heart of Research Triangle Park.  We invite you to join us along with other local industry leaders to discuss Value Based Medicine: The Collision of Innovation and Affordability.  See below for more details and click here to register.


Value Based Medicine: The Collision of Innovation and Affordability

Unprecedented advances in medical innovation are expanding life expectancy, improving quality of life, and even providing cures for life-threatening diseases. Yet the cost associated with this innovation now lies at the center of the national dialogue over cost, affordability, and access in health care.

Moderator

  • Susan Cantrell – Chief Executive Officer, Academy of Managed Care Pharma

Panelists

  • Jane Reese-Coulbourne, M.S., ChE – Senior Consultant, Mark Krueger & Associates
  • Janet McCauley, M.H.A., M.D. – Senior Medical Director, Blue Cross Blue Shield of North Carolina
  • Chris Little, PharmD, BCPS – Director, Pharmacy & Diagnostic Imaging, Resource Optimization & Innovation

Agenda

  • 4pm – Registration
  • 4:30pm – Panel Session
  • 6pm – Networking

To view full details of the event, click here

Kineticos to Sponsor the Q4 Life Science Forum

Kineticos is sponsoring the Q4 Life Sciences Forum on December 6th at the NC Biotech Center.  We invite you to join us along with other local industry leaders to discuss how Covis Pharma went from startup to a billion dollar exit.  See below for more details and click here to register.


From Startup to a Billion Dollar Exit – “The Covis Story”

What is the current and future landscape of the pharmaceutical and specialty pharma industry?  How can a start-up company navigate the legal, regulatory, cross-border structuring, life-cycle management and licensing challenges to build a billion dollar company?

Come hear relevant insights regarding the merger and financing environment, industry trends and developments, and how a company achieved worldwide sales growth through license agreements and efficient structuring that ultimately led to a billion dollar exit.

Panelists

  • Jack Davis – Former Chief Executive Officer, Covis Pharma
  • Sean King – President and Managing Director, Align Global Consulting
  • Banks Bourne – Chief Executive Officer/Sr. Managing Director, Bourne Partners

Moderator

  • Tim Gupton – Partner & Financial Advisor, HPG Wealthcare Advisors, LLC

Agenda

  • 4pm – Registration
  • 4:30pm – Panel Session
  • 6pm – Networking

To view full details of the event, click here

Kineticos Expands Biopharmaceutical Practice Leadership Team, Bolsters Oncology Focus with Senior Vice President Appointment

Consulting Firm Hires Senior Leader Within Biopharmaceutical Practice – 

October 28, 2016 – Raleigh-Durham, N.C. – Kineticos, a specialized strategy consulting firm serving the life sciences industry, today announced the expansion of its Biopharmaceutical practice leadership team with the addition of Glen Martin, Senior Vice President.

Glen Martin joins Kineticos as a seasoned executive with more than 22 years of experience in the biopharmaceutical industry. Mr. Martin held roles in sales for several start up biopharma companies before moving to Pharmion, a then-leading global oncology company. While at Pharmion, Mr. Martin held various management roles in sales before moving to Medical Affairs and becoming the National Director of the US Medical Science Liaison program. After Pharmion was acquired by Celgene in 2008, Glen took on responsibilities as Celgene’s Senior Director, Outcomes Research & Operations. Subsequently, Glen spent 4 years serving in the capacity of Chief of Staff for Celgene’s US Medical Affairs group before being recruited by Covis Pharma, a unique start up company, to serve as Vice President of Oncology Sales. Following the acquisition of Covis, Mr. Martin served as Senior Vice President, Medical Sciences for Ashfield Healthcare. Mr. Martin earned his BA in Psychology from LaSalle University in Philadelphia, PA.

“Glen adds extensive cross-functional experience to the practice along with an impressive track record of bringing new biopharmaceutical products to market with a focus on oncology,” stated Founder and CEO of Kineticos, Shailesh Maingi. “Our clients are the heart of our entrepreneurial consulting practice. Glen’s expertise adds depth to our existing consulting capabilities, especially in oncology which constitutes 40% of all active clinical trials, and adds more resources to our practice as an increasing number of biopharma clients depend on our team to guide their path to market,” he continued.

About the Biopharmaceutical Practice at Kineticos

The Biopharmaceutical practice at Kineticos assists growth-oriented pharmaceutical and biotech companies realize their commercial potential at the corporate, portfolio and product levels. The firm’s consulting team members have a depth of expertise across functional areas and therapeutic areas, established through decades of work in consulting and in industry. Overall, the practice has a strong commitment to client satisfaction and a proven ability to deliver results through practical solutions. The Biopharmaceutical practice at Kineticos supports clients across three service areas including corporate strategy & development, medical affairs strategy and commercial strategy. For more information on the Biopharmaceutical practice at Kineticos, please visit https://kineticos.com/life-science-consulting-companies/biopharmaceutical-practice/. 

About Kineticos

Kineticos is a specialized strategy consulting firm serving the life science industry.

At Kineticos, we have a simple mission: to help our sponsors solve their most complex problems. We work exclusively within the life sciences ecosystem. And our focus is strategy, business development & licensing, market access, innovation and operational excellence. Our values start with an entrepreneurial culture focused on exceptional outcomes for our sponsors through deep engagements. We foster an environment where our business and life science experts can be creative, critical and collaborative thinkers. We value context and transparency over hierarchy and control. We do all of this to improve patient outcomes, our shared purpose with our sponsors.